Form 4: Envista Executive Sells Shares for Tax Obligations

Envista Holdings Corp's President of Nobel Biocare, Stefan Nilsson, disposed of 804 common shares to cover tax withholding on vested restricted stock units.

Summary

• Stefan Nilsson, President of Nobel Biocare at Envista Holdings Corp (NVST), reported a transaction involving common stock.
• On August 25, 2025, Nilsson disposed of 804 shares of common stock.
• The shares were disposed of at a price of $21.12 per share.
• This transaction was identified as a tax withholding event (Code F) related to the vesting of stock-settled Restricted Stock Units.
• Following this transaction, Nilsson beneficially owns 54,941 shares of Envista Holdings Corp common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neutral in sentiment. It reflects the vesting of executive compensation but does not indicate any strategic or operational changes.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of previously granted Restricted Stock Units, which can be seen as a positive for executive compensation and retention.

Negatives

• No inherently negative aspects are indicated by this routine tax withholding transaction.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This routine insider transaction for tax purposes does not provide specific insights into broader industry trends or competitive dynamics. It is a standard event related to executive compensation.

Comparison to Industry Standards

• This filing reports a standard tax withholding transaction upon the vesting of restricted stock units, which is a common practice in executive compensation across various industries. It does not provide data for direct comparison to specific companies or projects.

Stakeholder Impact

• Shareholders: This routine transaction has minimal direct impact on shareholders, as it is a standard part of executive compensation and tax compliance. It does not signal a change in company fundamentals or strategy.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

Envista Holdings Corp, NVST, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Stefan Nilsson, Nobel Biocare, Restricted Stock Units